Data from early trials have shown. The phase one and phase two results suggest that...

Published: 3:18 am November 20, 2020
Updated: 8:25 am September 2, 2023
The COVID-19 vaccine developed by Oxford University produces a strong immune response in older adults – UKNIP
Data from early trials have shown.

The phase one and phase two results suggest that one of the groups most at risk of death or serious illness from COVID-19 may be able to build immunity, according to data published in The Lancet medical journal.

More news from Oxford

We are your go-to destination for breaking UK news, real-life stories from communities across the country, striking images, and must-see video from the heart of the action.

Follow us on Facebook at for the latest updates and developing stories, and stay connected on X (Twitter) the for live coverage as news breaks across the UK.

SIGN UP NOW FOR YOUR FREE DAILY BREAKING NEWS AND PICTURES NEWSLETTER

Your information will be used in accordance with our Privacy Policy

YOU MIGHT LIKE